Related Experiment Video
Updated: Jul 26, 2026
13:13
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Hypoglycemia in the neonate.
1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Seminars in Perinatology
|May 11, 2000
Summary
This review covers the current management of neonatal hypoglycemia, focusing on diagnosis and treatment. It highlights new definitions and approaches for this common newborn condition.
Area of Science:
- Neonatal Medicine
- Endocrinology
- Metabolic Disorders
Background:
- Neonatal hypoglycemia, a common condition, requires careful management.
- Historical approaches have evolved with advancements in understanding its effects.
Purpose of the Study:
- To review the current strategies for anticipating, diagnosing, and managing neonatal hypoglycemia.
- To discuss new definitions and treatment protocols for low plasma glucose concentrations in neonates.
Main Methods:
- Review of current literature and clinical practices.
- Analysis of neurophysiological and endocrine-metabolic effects of hypoglycemia.
- Incorporation of data from related studies on genetic and metabolic defects.
Main Results:
- Glucose oxidase strips are inadequate for reliable screening.
- New definitions for significant hypoglycemia and high-risk infants are proposed.
- The neonate's ability to respond to low glucose levels is examined.
Conclusions:
- Updated definitions and diagnostic criteria are crucial for effective management.
- Multifaceted approaches, including genetic and imaging techniques, enhance understanding.
- Optimal management strategies are essential to prevent long-term neurodevelopmental consequences.
Related Concept Videos
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...